Это видео недоступно.
Сожалеем об этом.
Lessons Learned from the 2023 EQA Schemes for Ovarian and Prostate Cancer
HTML-код
- Опубликовано: 14 авг 2024
- On the 6th June 2024, Dr. Simon Patton (CEO, EMQN CIC) and Prof. Sandi Deans (Director, GenQA) hosted a webinar discussing lessons learned from the 2023 EQA scheme for BRCA (and other HRR) genes in Ovarian and Prostate Cancer. The webinar covered
- Overview of results from the 2023 Molecular testing of BRCA and other HRR gene variants EQA schemes.
- Clear examples of the errors and pitfalls seen in the EQA.
- Practical solutions, which when implemented may help prevent / rectify common issues.
- Guidance on reporting results within different clinical contexts.
